Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Polyethylene glycol (PEG) + electrolytes + ascorbic acid is an osmotic bowel cleansing preparation used to clear the colon in preparation for colonoscopy or other gastrointestinal procedures. It typically consists of PEG 3350, electrolytes (such as sodium sulfate, sodium chloride, and potassium chloride), and a high dose of ascorbic acid (Vitamin C) and sodium ascorbate. The PEG and electrolytes work by retaining water in the intestinal lumen, while the ascorbic acid components act as additional osmotic agents. This combination allows for effective bowel cleansing with lower fluid volumes (e.g., 1L or 2L) compared to traditional 4L PEG solutions, which can improve patient compliance and tolerability.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on polyethylene glycol + electrolytes + ascorbic acid.